Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope.

Monoclonal antibody L9 recognizes the Plasmodium falciparum circumsporozoite protein (PfCSP) and is highly protective following controlled human malaria challenge. To gain insight into its function, we determined cryoelectron microscopy (cryo-EM) structures of L9 in complex with full-length PfCSP and assessed how this recognition influenced protection by wild-type and mutant L9s. Cryo-EM reconstructions at 3.6- and 3.7-Å resolution revealed L9 to recognize PfCSP as an atypical trimer. Each of the three L9s in the trimer directly recognized an Asn-Pro-Asn-Val (NPNV) tetrapeptide on PfCSP and interacted homotypically to facilitate L9-trimer assembly. We analyzed peptides containing different repeat tetrapeptides for binding to wild-type and mutant L9s to delineate epitope and homotypic components of L9 recognition; we found both components necessary for potent malaria protection. Last, we found the 27-residue stretch recognized by L9 to be highly conserved in P. falciparum isolates, suggesting the newly revealed complete L9 epitope to be an attractive vaccine target.

• Publication year

  2023

• Venue

  Structure

• Publication date

  2023-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.str.2023.02.009PMID 36931276PMCID PMC10237622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire

  2022cited by this paper
• Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.

  2022cited by this paper
• Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.

  2022cited by this paper
• The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

  2021cited by this paper
• The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo

  2021cited by this paper
• Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

  2021cited by this paper
• A Monoclonal Antibody for Malaria Prevention.

  2021cited by this paper
• Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum

  2020cited by this paper
• A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.

  2020cited by this paper
• cAb-Rep: A Database of Curated Antibody Repertoires for Exploring Antibody Diversity and Predicting Antibody Prevalence

  2019cited by this paper
• Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages

  2019cited by this paper
• Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122

  2019cited by this paper
• Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.

  2019cited by this paper
• Malaria prevention: from immunological concepts to effective vaccines and protective antibodies

  2018cited by this paper
• UCSF ChimeraX: Meeting modern challenges in visualization and analysis

  2018cited by this paper
• A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein

  2018cited by this paper
• MolProbity: More and better reference data for improved all‐atom structure validation

  2018cited by this paper
• Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts

  2018cited by this paper
• A human monoclonal antibody prevents malaria infection and defines a new site of vulnerability on Plasmodium falciparum circumsporozoite protein

  2018cited by this paper
• Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope

  2018cited by this paper
• Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

  2017cited by this paper
• Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation

  2017cited by this paper
• Teaching a Clone to Walk, One Step at a Time.

  2016cited by this paper
• Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.

  2016cited by this paper
• EMRinger: Side-chain-directed model and map validation for 3D Electron Cryomicroscopy

  2015cited by this paper
• Development of a Chimeric Plasmodium berghei Strain Expressing the Repeat Region of the P. vivax Circumsporozoite Protein for In Vivo Evaluation of Vaccine Efficacy

  2013cited by this paper
• A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

  2012cited by this paper
• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  2011cited by this paper
• IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

  2008cited by this paper
• Inference of macromolecular assemblies from crystalline state.

  2007cited by this paper
• Crystal structure of an NPNA-repeat motif from the circumsporozoite protein of the malaria parasite Plasmodium falciparum.

  2006cited by this paper
• MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes

  2004cited by this paper
• WebLogo: a sequence logo generator.

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR.

  1990cited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• Machine learning enables de novo multiepitope design of Plasmodium falciparum circumsporozoite protein to target trimeric L9 antibody

  2025influential citation
• Anti-Malaria Antibody Engineering Broadens Recognition Motifs and Reveals New Homotypic Interactions that Enhance Protective Breadth

  2025cites this paper
• Deep learning-enabled scaffolding of spatial arrays of PfCSP epitopes

  2025influential citation
• A Single Structure-Derived Computational Metric Predicts High-Affinity Antibody Selection Against a Malaria Antigen

  2025cites this paper
• Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats

  2025cites this paper
• Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions

  2025cites this paper
• Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens

  2025cites this paper
• Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies

  2025cites this paper
• Comparison of major, minor and junctional circumsporozoite protein epitopes for malaria vaccine design

  2025cites this paper
• Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention

  2024influential citation
• Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats

  2023influential citation
• Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein

  2023cites this paper